EurekAlert! - National Institutes of Health

Showing releases 1-25 out of 112 releases.
Click to go to page: [ 1 | 2 | 3 | 4 | 5 ]

Public Release: 9-Nov-2009

Proceedings of the National Academy of Sciences
Words, gestures are translated by same brain regions, says new research
Researchers have shown that the brain regions that have long been recognized as a center in which spoken or written words are decoded are also important in interpreting wordless gestures. The findings suggest that these brain regions may play a much broader role in the interpretation of symbols than researchers have thought and, for this reason, could be the evolutionary starting point from which language originated.

NIH/National Institute on Deafness and Other Communication Disorders

Public Release: 6-Nov-2009
NHLBI stops enrollment in study on resuscitation methods for cardiac arrest
Enrollment has ended early in a large, multi-center clinical trial comparing two distinct resuscitation strategies delivered by emergency medical service providers to increase blood flow during cardiac arrest. The study's independent monitoring board and the National Heart, Lung and Blood Institute, the lead sponsor of the study, stopped enrollment based on preliminary data suggesting that neither strategy significantly improved survival.

NIH/National Heart, Lung and Blood Institute

Public Release: 4-Nov-2009
NIAID announces new human immunology research awards to help fight emerging infectious diseases
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 4-Nov-2009
NIAID awards five-year, $56 million contract to continue study of asthma in inner-city children
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has renewed the contract to continue studying asthma in children living in lower-income, inner-city environments. This five-year, $56 million award will support the Inner-City Asthma Consortium , a nationwide clinical trials network to evaluate promising new therapies to reduce asthma severity and prevent disease, and to perform basic research to understand how these therapies work.

NIH/ National Institute of Allergy and Infectious Diseases

Public Release: 2-Nov-2009
Initial results show pregnant women mount strong immune response to 1 dose of 2009 H1N1 vaccine
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 2-Nov-2009
New EUREKA awards fund highly innovative research, promise big payoffs
The National Institutes of Health has awarded 56 grants of up to $67.4 million to support highly innovative research projects that promise big scientific payoffs.

National Institutes of Health

Public Release: 2-Nov-2009
Survey: Awareness of COPD is rising, but understanding is still low
Awareness of COPD -- chronic obstructive pulmonary disease -- continues to grow in the United States, according to national survey results released today by the National Heart, Lung and Blood Institute of the National Institutes of Health.

NIH/National Heart, Lung and Blood Institute

Public Release: 2-Nov-2009
Clinical tests begin on medication to correct Fragile X defect
NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability and optimal dosage in healthy volunteers.

National Institutes of Health

Public Release: 30-Oct-2009

Experimental Biology and Medicine
Researchers develop innovative imaging system to study sudden cardiac arrest
A research team at Vanderbilt University has developed an innovative optical system to simultaneously image electrical activity and metabolic properties in the same region of a heart, to study the complex mechanisms that lead to sudden cardiac arrest.

NIH/National Heart, Lung, and Blood Institute, Vanderbilt Institute for Integrative Biosystems Research and Education, American Heart Association, Simons Center for Systems Biology at the Institute for Advanced Study

Public Release: 30-Oct-2009

Journal of Infectious Diseases
Media availability: The role of biomedical research in malaria eradication
Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year. In 2007, Bill and Melinda Gates called for a renewed effort to eradicate malaria worldwide. Some skeptics have questioned the feasibility of doing so because of failed attempts to eradicate malaria in the 20th century.

NIAID

Public Release: 30-Oct-2009

47th Annual Meeting of the Infectious Diseases Society of America
Progress made on Group B streptococcus vaccine
Scientists supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have completed a phase II clinical study that indicates a vaccine to prevent Group B Streptococcus infection is possible.

Public Release: 29-Oct-2009
NIH launches multicenter clinical trial to test blood pressure strategy
The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline.

National Institutes of Health

Public Release: 29-Oct-2009

Science
NIAID scientists propose new explanation for flu virus antigenic drift
Influenza viruses evade infection-fighting antibodies by constantly changing the shape of their major surface protein. Now, researchers from NIH/National Institute of Allergy and Infectious Diseases have proposed a new explanation for the evolutionary forces that drive antigenic drift.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 28-Oct-2009
NIEHS awards Recovery Act funds to address bisphenol A research gaps
Researchers studying the health effects of the chemical bisphenol A (BPA) gathered in North Carolina to launch an integrated research initiative to produce data that will allow for a comprehensive assessment of its possible human health effects.

NIH/National Institute of Environmental Health Sciences

Public Release: 28-Oct-2009
Recovery Act funds expand studies of stem cell biology
NIH's National Institute of General Medical Sciences is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.

NIH/National Institute of General Medical Sciences

Public Release: 28-Oct-2009

Lancet
A decade later, lifestyle changes or metformin still lower type 2 diabetes risk
Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data.

Public Release: 28-Oct-2009

Nature
NIH-funded researchers transform embryonic stem cells into human germ cells
Researchers funded in part by the National Institutes of Health have discovered how to transform human embryonic stem cells into germ cells, the embryonic cells that ultimately give rise to sperm and eggs. The advance will allow researchers to observe human germ cells -- previously inaccessible -- in laboratory dishes.

National Institutes of Health

Public Release: 21-Oct-2009

New England Journal of Medicine
Study conclusively ties rare disease gene to Parkinson's
An international team led by a National Institutes of Health researcher has found that carriers of a rare, genetic condition called Gaucher disease face a risk of developing Parkinson's disease more than five times greater than the general public. The findings were published today in the New England Journal of Medicine.

National Institutes of Health

Public Release: 16-Oct-2009
NIH launches second phase of patient reported outcomes initiative
The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System. Managed by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, PROMIS aims to revolutionize the way patient reported outcome tools are selected and employed in clinical research and practice.

National Institutes of Health

Public Release: 15-Oct-2009

Science
Scientists discover protein receptor for carbonation taste
Scientists report they have discovered the protein receptor for carbonatoin in mice, whose sense of taste closely resembles that of humans.

NIH/National Institute of Dental and Craniofacial Research, Howard Hughes Medical Institute

Public Release: 12-Oct-2009

Archives of Neurology
Investment in Parkinson's disease data bank yields potential therapy
Individuals with Parkinson's disease who have higher levels of a metabolite called urate in their blood and in cerebrospinal fluid (CSF) have a slower rate of disease progression, according to a study funded by the National Institutes of Health. A clinical trial is under way to examine the safety and potential benefits of supplemental urate elevation for recently diagnosed Parkinson's patients who have low urate levels.

National Institutes of Health, Michael J. Fox Foundation

Public Release: 9-Oct-2009
NIH prepares to launch 2009 H1N1 influenza vaccine trial in people with asthma
The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease. The study is cosponsored by the National Institute of Allergy and Infectious Diseases and the National Heart, Lung and Blood Institute, both part of NIH.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 9-Oct-2009
NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week. The International Maternal Pediatric Adolescent AIDS Clinical Trials Group is conducting the studies, which are sponsored and funded by the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 8-Oct-2009

Symposium on Cardiovascular Regenerative Medicine
NHLBI to convene symposium on cardiovascular regenerative medicine
With advancements in the field of stem cell research accelerating, the National Heart, Lung and Blood Institute of the National Institutes of Health will hold its third Symposium on Cardiovascular Regenerative Medicine to review the latest findings in the field and examine future directions. The symposium will include a discussion on ways to move promising findings in the laboratory into clinical trials, in hopes of speeding stem cell-related treatments to patients.

Public Release: 8-Oct-2009
NIAID announces vaccine adjuvant discovery contracts
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded six new research contracts to discover and characterize novel adjuvants, substances that can be added to vaccines to enhance the protective immune response they induce.

NIH/National Institute of Allergy and Infectious Diseases

Showing releases 1-25 out of 112 releases.
Click to go to page: [ 1 | 2 | 3 | 4 | 5 ]